OSLO, Norway & BOSTON–(BUSINESS WIRE)–ClexBio, an early-stage biotech company developing next-generation tissue engineered grafts for transplant, is announcing the appointment of two new members to its Board of Directors. Joining the board with immediate effect are Andreas Lehmann as non-executive Chairman and Wasim Malik as independent Director. Armend G. Håti, Co-Founder and CEO of ClexBio, … [Read more…]
Insights by Dr. Mansureh Kebritchi draw on data from 2022 Career Optimism Index® study PHOENIX–(BUSINESS WIRE)–University of Phoenix College of Doctoral Studies announces the release of a new whitepaper by Mansureh Kebritchi, Ph.D., chair, Center for Educational and Instructional Technology Research (CEITR) within the College of Doctoral Studies, which draws upon data from the 2022 … [Read more…]
BIRMINGHAM, Ala.–(BUSINESS WIRE)–ProAssurance Corporation (NYSE:PRA) will report results for the quarter ended June 30, 2022 after the close of normal New York Stock Exchange trading on Monday, August 8, 2022. ProAssurance will conduct a conference call at 10:00 AM ET on Tuesday, August 9, 2022 to discuss the results and other items of interest to … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Severe Hypertriglyceridemia (SHTG) – Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. This report deliver an in-depth understanding of the Severe Hypertriglyceridemia, historical and forecasted epidemiology as well as the Severe Hypertriglyceridemia market trends in the United States, EU5 (Germany, France, Italy, Spain, and the United … [Read more…]
Meets the Growing Need for US-Based API Solubility and Bioavailability Enhancement Services QUAKERTOWN, Pa.–(BUSINESS WIRE)–Microsize today announced the launch of its business as an independent company to support solubility and bioavailability enhancement via particle reduction technologies including micronization. This announcement marks the completion of the previously announced intent to acquire the North American micronization business … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the company has joined an initiative created by the Department of Health and Human Services (HHS), in partnership with the White House, to address climate action through the reduction of greenhouse gas emissions. Earlier this week at the White … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “APAC Clinical Diagnostics Market 2021-2031” report has been added to ResearchAndMarkets.com’s offering. Asia Pacific clinical diagnostics market will grow by 9.8% annually with a total addressable market cap of $257.46 billion over 2022-2031, driven by the rising patient awareness and rising demand for high-quality care, growing healthcare spend, technological advancement, benefits of clinical … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Direct-acting Antiviral Drug Market Research Report by Type (NS3/4A Protease, NS5A Protein, and NS5B RNA-Dependent RNA polymerase), Indication, Route, Distribution Channel, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Direct-acting Antiviral Drug Market size was estimated at USD 1,676.39 … [Read more…]
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–IgGenix, Inc., a biotechnology company taking a revolutionary approach to directly alleviate allergic disease, today announced insights from its novel SeqSifter™ single-cell RNA-sequencing discovery platform demonstrating the potential for IgE antibody re-engineering in tree nut allergy. These data will be presented during the 2022 European Academy of Allergy and Clinical Immunology … [Read more…]
HIMALAYA Phase III trial subgroup analysis showed that IMFINZI plus tremelimumab improved overall survival vs. sorafenib in patients with unresectable liver cancer regardless of baseline liver functional reserve TOPAZ-1 Phase III trial subgroup analysis showed the addition of IMFINZI to standard-of-care chemotherapy improved overall survival benefit in patients with advanced biliary tract cancer regardless of … [Read more…]
